Financials
- Market Capitalization 524.43 M
- Employee 149
- Founded 2018
- CEO N/A
- Website www.kyvernatx.com
- Headquarter Delaware, United States
- FIGI BBG00RCYMHR1
- Industry Биотехнологии
Общий доход
Чистая прибыль
Базовая прибыль на акцию
Общий долг
Свободный денежный поток
Денежные средства и эквиваленты
Related tickers
| # | Название | Цена | 24ч % | 7д % | 1М % | 1Г % | Капитализация | Последние 7 дней | |
|---|---|---|---|---|---|---|---|---|---|
| 2885 | OVID Ovid Therapeutics Inc. - Common Stock | 2.67 USD | -4.64% | -6.32% | +20.27% | +113.60% | 521.45 M USD | ||
| 2892 | ENTX Entera Bio Ltd. - Ordinary Shares | 2.95 USD | -2.64% | -13.74% | +1.37% | +52.06% | 510.77 M USD | ||
| 2940 | EVMN Evommune, Inc. Common Stock | 13.22 USD | -1.56% | -5.57% | +18.67% | -23.67% | 479.78 M USD | ||
| 2948 | PRTA Prothena Corporation plc - Ordinary Shares | 9.35 USD | +0.21% | -1.68% | +14.44% | +14.44% | 480.00 M USD |